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Magnetic resonance imaging (MRI) is often championed in
medical research circles because the modality is generally
deemed safe and may be performed repeatedly. However, it is
also clear that MRI research carries risks.  As discussed in this
paper, the legal and ethical standard for disclosure of risks in
research requires that all known and foreseeable risks must be
disclosed to the research participant or substituted decision-
maker. Given these two facts, one would expect that a clear,
concise, and complete description of the risks of MRI would be
available in the literature; however, this is not so.  After a perusal
of the literature, we could find only limited risk descriptions.
While MRI risks have indeed been described in the literature,1-3
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no article is comprehensive, detailing all risks. This detailed list
and MRI safety information would be of great use to the
neurological science community. This paper brings together
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information on the Canadian standard of disclosure of research
risks and the risks of MRI research. Recommendations will also
be made concerning areas in need of further investigation, risk
reduction strategies and important criteria for the composition of
consent forms and research protocols in order to meet the
Canadian disclosure standard. 
A literature review was undertaken in order to assemble a
comprehensive overview of physical and psychological risks
associated with MRI. Searches were carried out using PubMed,
Ovid Online, and PsychINFO databases using search terms such
as, “safety and MRI/magnetic field,” “risk and MRI/magnetic
field,” “claustrophobia/anxiety and MRI,” and others. In
addition, searches were made using publicly available
information from the Canadian Medical Association (CMA), the
American Medical Association (AMA), the American Academy
of Neurology (AAN), the American College Radiology (ACR),
the US FDA, Health Canada, the American Society of
Anesthesiologists (ASA), American Academy of Pediatrics
(AAP), the Joint Commission on Accreditation of Healthcare
Organizations (JCAHO) and MRI Safety websites. 
This précis is intended to assist Research Ethics Boards
(REBs) when reviewing protocols and consent forms and to
educate more broadly on MRI research risks. To that end, the
current legal and ethical standard for disclosure of risks for
research involving humans in Canada will be explained. A
synthesis of the physical and psychological risks associated with
MRI research will then be provided. A sample template text of all
MRI risks is available at www.neuroethics.ca for use by
researchers and REBs.
This paper specifically focuses on risks of MRI research and
the need for full disclosure of these risks. The issue of disclosure
of risks in a clinical (as opposed to research) context, as well as
issues surrounding the risks of fMRI (functional MRI), and other
emerging neuroethics topics such as thought privacy or
neuroimaging databases will not be examined in this paper.
I. CURRENT STANDARDS
Disclosure
In Canada, the legal standard of disclosure of risks for
research with no intended benefit for participants has been
addressed by two court decisions.  In Halushka v. University of
Saskatchewan, the Saskatchewan Court of Appeal established
that the duty of disclosure of investigators to research
participants is “at least as great as, if not greater than, the duty
owed by the ordinary physician or surgeon to his patient” (1965),
53 D.L.R. (2d) 436 (Sask. C.A.). The court also found that the
physician privilege of withholding information from the patient
“so that he should not worry” has no application in the research
context (Ibid., at 444). In Weiss v. Solomon, the Quebec
Supreme Court established that all risks, even those rare and
remote, must be disclosed to the research participant, especially
if these risks could have serious consequences. The court in
Weiss based its decision on the disclosure requirements found in
Halushka as well as the Declaration of Helsinki and the Civil
Code of Quebec.4
Beyond the courts, the Tri-Council Policy Statement on
Research Involving Humans (TCPS)  upholds that research
participants must be provided with “a comprehensible
description of reasonably foreseeable harms and benefits that
may arise from research participation” (Art. 2.4c).5 Moreover,
the TCPS requires that information regarding the “potential for
physical or psychological harm” is also described to research
participants (Art. 2.4 c).5
In summary, the current standard for disclosure for research
involving humans in Canada is that all known and foreseeable
risks—even those rare and remote—must be disclosed to the
research participant or their substitute decision-maker. This
means that when an investigator prepares, or an REB reviews,
MRI research protocols and consent forms, care must be taken to
ensure that all known and foreseeable risks are disclosed. The
following is a description of the risks of MRI research as well as
risk reduction strategies.
II. RISK SYNTHESIS
In this paper, MRI research risks have been broadly divided
into two categories: physical and psychological. The MRI risks
may also be categorized by those risks that are directly related to
the MRI system or are associated with secondary procedures
(e.g., sedation, contrast injection). Further risks could also be




Magnetic resonance imaging systems use a strong static
magnetic field, a pulsed gradient magnetic field and
radiofrequency (RF) energy to obtain images of the body in
selected planes.6 A potentially problematic component of the MR
environment is the strong static magnetic field (up to 100 000
times the magnetic field strength of the earth) that is always
present even when the scanner is not imaging.7 The pulsed
gradient magnetic field used for signal localization and the RF
coils used to elicit MR signals from tissue may also have
potential risks. Some risks associated with the MRI magnet are




Metal objects (e.g., oxygen bottles, IV poles, pens, hair
barrettes) can be strongly attracted to the MRI magnet (the
“missile effect”) and could cause serious injury to anyone in the
MRI environment. For example, a hair barrette near a 1.5 T MRI
magnet can reach speeds of 40 mph (about 60 km/h).7 The ACR
published its White Paper on MR Safety after an oxygen tank
struck and killed a young boy during an MRI exam.8
The magnet may also cause metallic implants inside the body to
move or electrically conductive material to heat up potentially
causing severe burns. Therefore, implants such as, aneurysm
clips are contraindications to MRI and scanning should not be
performed where they are present.7 A detailed list of MRI
compatible surgical materials has been compiled to help
determine patient and research participant safety during MRI
examinations.9
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An increasing number of people have implantable electronic
or magnetic devices (i.e. pacemakers, defibrillators, cochlear
implants) that can be disrupted by an MRI magnet, especially at
the powerful field strengths that are presently in use. In some
cases, medical devices are therefore contraindications to MRI
and scanning should not be performed.7,9
The risks associated with metal in or around the magnet can
be reduced through such strategies as screening questionnaires,
preparatory CT scans, thermally insulating electrically
conducive material and the use of MR compatible devices.1
Human tissues have very low magnetic susceptibility and lack
enough ferromagnetic material to lead to harm due to MR
imaging.10 To date there have been well over 100 million MRI
examinations performed, and no evidence has appeared to
support a claim that exposure to the magnetic field is unsafe at
regulatory levels.11 In 2003, the US FDA published new criteria
for MRI devices limiting field strengths to 8 Tesla for adults,
children and infants older than one month and 4T for neonates
and infants.12,13 This new standard for MRI scanners provides a
field strength threshold beyond which FDA ethical approval
would be needed. Current Canadian guidance on MRI safety
limits is considered outdate.14 Thus, Canadian researchers and
clinicians must rely on the FDA guidelines which are more
complete and accessible. Updated Canadian guidelines need to
be provided by the appropriate regulatory agency.
Time-Varying RF Magnetic Field
While many hypothetical mechanisms for bioeffects of the
RF field have been proposed, the only accepted biological
concern is heating.1,15-17 Sensations of warmth occur only rarely
and are always temporary.14 The amount of RF energy deposited
in the patient during an MRI exam depends on the static
magnetic field strength, the amount of energy applied by the RF
pulse (number of pulses, type(s) of pulse(s), including flip angle
and waveform), anatomy imaged, patient size, and coil design.
The magnetic induction, however, occurs at the surface where
heat dissipates more readily into the environment.15,18 The MRI
system fans typically provide sufficient cooling from the
increased temperature caused by RF absorption. It is therefore
important that the fan is running during high energy sequences. 
The RF energy absorbed by the patient can be calculated in
terms of Watts/kg and is known as the specific absorption rate
(SAR). Specific absorption rate is limited by FDA and Health
Canada regulations and depends on certain environmental
conditions, such as temperature, humidity, air and blood flow
rates and insulation.  The typical human metabolic rate is
approximately 1.3 Watts/kg, while highly trained athletes raise
their metabolic rate to nearly 18 Watts/kg during vigorous
exercises. The SAR for MRI exams is well below this level of
vigorous exercise.15,18
Danger of localized heating exists where the subject may be
exposed to sources of higher electric fields, for example, if they
are near transmit coils, or they contact the magnet bore (as can
happen with larger patients).  Padding can be used to insulate the
subject from these effects and formations of closed loops, such
as the subject clasping hands, should be avoided.  Heating should
be limited when using local transmit coils to prevent burns.18
Researchers and REBs should pay particular attention to
potential heating problems when new coils are being tested. 
At higher field strengths, MRI may also induce an electric
field within the body that can cause peripheral nerve stimulation
or tingling producing an unpleasant or even painful sensation.1
Considered a serious concern by the US FDA, patients have also
reported seeing spots (magnetophosphenes) thought to result
from a slight torque (movement created by magnetic material
aligning with the MRI magnet) created by the pulsed gradient
magnetic field exerted on the retinal cones.7 These effects
disappear when exposure ceases and do not affect visual acuity,
presenting no apparent health hazard.17 As with SAR, there are
safety regulations limiting the rates of change in magnetic flux
density produced by the gradient coils (dB/dt).7,13
Noise
The loud acoustic noise that can be produced by the MRI
scanner could cause hearing loss if appropriate sound protection
is not used.3 The factors that can affect the amount of hearing
damage include the duration of the sound, frequency, intensity
and temporal pattern. Modern MRI systems have significantly
reduced noise levels, however, appropriate hearing protection is
still recommended. Furthermore, certain drugs are known to
increase hearing sensitivity and so the risk of physical
discomfort may be increased in some individuals.19 In addition,
neonates with immature anatomic development may react
strongly to the loud noise of the MRI scanner.20 Sedated patients
also have an increased sensitivity to sudden and frequently
monotonous MR noise.12
Ear plugs and/or headphones are typically employed to
reduce this risk to hearing. For infants, soft ear putty and mini-
muff ear protection should be used.12 The risk can be reduced by
using scanners that do not output the continuous maximum noise
level associated with hearing loss.
WORK IN NEED OF FURTHER RESEARCH
Magnetic field
While MRI is considered to be relatively safe at higher
magnetic field strengths (i.e., 8 Tesla for adults, 4 Tesla for
neonates), an insufficient number of well-designed, controlled
human studies have been conducted to justify claims of absolute
safety.14 In the same way, long-term health risks from the
magnetic field or radio frequency waves have not been proven.
Furthermore, MR physics does not suggest that there would be
any harmful effects of exposure to MRI within the approved
guidelines. Nevertheless, long-term epidemiological studies
have yet to be performed in order to unequivocally prove this.
Although absolute safety may be difficult if not impossible to
empirically demonstrate,1 short-term exposures have been
extensively studied. Most of these studies conclude that there are
no substantial harmful biologic effects to short-term exposure.1
Furthermore, the literature does not contain carefully controlled
experiments demonstrating absolute safety with chronic
exposure to strong magnetic fields.1,21 A commitment to disclose
new findings about previously unknown risks should be made by
the researcher to the REB and to research participants.
Pregnancy
To date, clinical MRI has produced no known deleterious
effects during pregnancy.1 Nevertheless, the research community
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has generally refrained from imaging pregnant women unless the
anticipated benefits are thought to outweigh the unknown risks.22
In any case, additional research is needed in order to determine
whether MRI is safe during pregnancy.1 For example, a large
scale retrospective chart review of those women who received a
clinical MRI during pregnancy and children born of women who
received a clinical MRI during pregnancy could be initiated.  
B. Secondary procedures
Physical risks can arise from the MRI examination process
that are not directly related to the MRI magnet. The
administration of sedation or contrast enhancement, though not
always required during the MRI exam, can carry potential
serious risks for the research participant. In addition, unexpected
findings can lead to additional unnecessary medical
examinations that may carry potential physical (and
psychological) risks. These risks, not directly related to the MRI
magnet, are described below.
Sedation
The vast majority of individuals undergoing an MRI scan do
not require sedation or anesthesia. However, under certain
circumstances such as cognitive impairment, claustrophobia,
severe pain or critical illness, sedation may be required.2 The
risks of sedation (depending on the drug used, level of sedation,
and age of participant, among other factors) commonly include
drowsiness, confusion, impaired judgment, nausea, and
vomiting. Rarely, complications may include difficulty
breathing, brain damage, and death (1:250 000).23
After the MRI research scan, there may be residual risks
while the research participant recovers from sedation. Children
may be particularly vulnerable to a prolonged recovery from, and
side effects of, sedation.24 These risks could be heightened when
children have been released from care.
For safety while sedated, breathing, heart rate (ECG), blood
oxygen level (pulse oximeters) and body temperature are
monitored. Due to the powerful magnetic field and RF
generation, the monitoring equipment may cause severe burns if
appropriate precautions are not taken (i.e. MRI-compatible
equipment, wire insulation, avoiding wire coiling).25 If the
research participant has been sedated, the risk of serious injury
may be greater.7
The risks associated with the use of sedation can be reduced
through various strategies. For instance, there are well-
developed sedation guidelines by the American Society of
Anesthesiologists,26 American Academy of Pediatrics24,25 and 
the Joint Commission on Accreditation of Healthcare
Organizations.27 Trained personnel can be assigned to monitor
the research participant while they are sedated and until they
have sufficiently recovered from sedation. 
These risks and the use of risk reduction strategies should be
explained in the protocol and consent form. Parents or guardians
can be educated regarding the potential for delayed adverse
events and the need for continued observation at home.
Contrast enhancement
Contrast agents, usually gadolinium-based mixtures, may be
used to improve contrast between tissue types. The injection of
contrast agents through an IV needle can cause discomfort,
generalized coldness, a tingling sensation in the throat, nausea,
hives or, headache.1 Although very rare, some allergic reactions
to contrast agents may be life-threatening (about 0.0003%
incidence). The total incidence of adverse events for MRI
contrast agents is less than 5%.9 According to the ACR White
Paper on MR Safety, the risks of MRI contrast agents are
sufficiently high that they should not be routinely used in
pregnant patients22 and, therefore, should never be used in
pregnant research participants.
The risks associated with the use of contrast agents can be
reduced through such strategies as ensuring the presence of
healthcare workers and resuscitation equipment at the scene.  
Unnecessary additional examinations
Magnetic resonance imaging research gives rise to the
possible discovery of unexpected findings, such as an
abnormality or disease. According to several articles on the
discovery of unexpected findings, one to two percent of adult
and paediatric research participants’ MRI research examinations
reveal medically significant findings (e.g. tumours,
aneurysms).28,29 As a result of the detection of unexpected
findings, a research participant may require invasive
examinations with the attendant potential for related medical
complications. Occasionally these examinations will lead to
discovery of treatable conditions. Sometimes, however, these
findings will reveal nothing and therefore the increased physical
risks of the ultimately unnecessary additional examinations will
have been carried out with no attendant benefit. The potential for
physical risks under these circumstances needs to be disclosed.
PSYCHOLOGICAL RISKS
Magnetic resonance imaging scans present psychological
risks, though they are not intrinsic to the imaging technology.
They are not, for example, the result of the magnetic field
directly affecting the brain. Negative psychological effects are
instead due to situational characteristics, probably including the
closeness of the scanner bore, the loud noise it makes, the long
duration of required immobility, and the patient's anxiety about
what the test may reveal.30,31 Exacerbating or secondary
circumstances may also influence levels of anxiety during a MRI
exam. The MRI noise can result in verbal communication
difficulties during the MRI exam and/or heightened anxiety or
discomfort in individuals with psychiatric disorders or those
individuals that need to be sedated, the elderly or paediatric
patients.1 Individuals with psychiatric illnesses may be
predisposed to suffer greater distress during MRI procedures.32
All of these stimuli may lead to both transitory and long-term
negative effects.
A. Transitory effects
The MRI scan situation may produce fear or distress during
the scan itself, and at times immediately preceding or following
the scan. These reactions are variously described (though rarely
defined) in research reports as fear, anxiety, panic, or
claustrophobia. 
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Panic
Patients receiving MRI scans sometimes experience panic,
often resulting in scan termination. Panic was diagnosed in 46 of
3000 adults (1.5%) undergoing an MRI exam,33 according to
whether the attending physician observed at least four out of ten
clinical symptoms (e.g. chest pain, vertigo, sweating, and
nausea). 
A larger proportion of self-reported panic was observed in a
sample of 80 adults.34 Following their scans, subjects read a brief
description of a panic episode, and then stated whether or not
they had experienced panic during the scan. Eleven (13.8%)
subjects answered affirmatively; three of these had terminated
the scan early. 
Self-reported anxiety
Researchers have measured fear by delivering brief
questionnaires that require patients to rate agreement with
statements about their feelings, usually on a 4 or 5 point Likert
scale. The "state" portion of the State-Trait Anxiety Inventory
(STAI) has been used most frequently, and consists of 20 items
with which respondents may agree not at all (1 point), somewhat
(2 points), moderately so (3 points), or very much so (4 points).
Final scores therefore range from 20 to 80, and normal (mean)
values for state anxiety in a healthy adult population are 38.1
(SD=10.1) for women, and 37.3 (SD=9.8) for men.35
Risk is described usefully by identifying the relative
frequencies of various magnitudes of harm. We wish to know, for
example, the proportions of patients who report mild, moderate,
or severe distress levels. Unfortunately, characterizing risk has
not been the focus of most studies that measured distress caused
by MRI scans. 
In two studies, post-scan STAI questionnaire items were
reworded to require retrospective evaluation of anxiety
experienced during the scans. One study found a mean state
anxiety level of 37.1 (SD=11.6) among men, and 43.1 (SD=14.6)
among women.36 The other study reported an overall mean state
anxiety score of 38.54 (SD 13.0).37 In a number of other
studies,31,38-41 state anxiety was measured both before and after
MRI scans, but the post-scan questions requested current, not
retrospective reports. Pre-scan anxiety sample means in these
studies ranged from 35.5 to 47.31. Post-scan means ranged from
33.0 to 45.24.
B. Long-term effects
The psychological effects of MRI scans may include learning,
meaning that however a patient responds during an MRI scan,
his or her future responses to the same or similar situations may
conceivably be affected.
Effects on future MRI reactions
Fear responses to MRI scans could sensitize or habituate,
meaning that a patient might report more or less fear,
respectively, the next time that an MRI situation is experienced
or contemplated. The best evidence for this effect would come
from repeated fear measurements of the same participants across
multiple MRI scans, but to date no such data are available. Fear
measurements from a single scan can also indicate learned
reactions if participants with previous scanning experience are
compared to those without it. In one such study,40 pre-scan
anxiety ratings were not significantly different between those
who had previously had MRI experience and those who had not.
Some evidence that patients habituate to the MRI experience,
even if initially stressful, comes from the success of exposure-
based treatments for MRI scan anxiety 42.42,43 These procedures
involve repeatedly presenting the fear-eliciting stimuli and
situations under controlled conditions, with the result (in both
studies cited) that the situations come to elicit little or no fear.
Claustrophobia
Of great concern is the possibility that an MRI experience
may increase fear responses to new (but probably related)
stimuli and situations. Could MRI scans cause claustrophobia, in
other words—a disorder characterized by the marked, persistent
and excessive fear of enclosed spaces?32 As with sensitization/
habituation, strong evidence would involve measurements of
claustrophobic behaviour recorded in the problem situation(s)
both before and after the MRI scan. For example, a patient may
receive a scan, experience distress, and subsequently experience
a panic attack while trapped briefly in a small elevator. But
unless the patient had been similarly confined before the scan
and had experienced much less anxiety, the claim that the scan
was responsible for the panic attack would be weak. 
At least one published report apparently describes this
phenomenon. Two adults without history of claustrophobia but
who had trouble tolerating MRI scans subsequently reported
persistent claustrophobia requiring psychiatric treatment.44 The
authors acknowledged that case reports should be regarded
cautiously in the absence of experimental demonstrations,
however, and urged additional research.
Fear and anxiety questionnaires (such as the STAI) delivered
prior to MRI scans have in several subsequent studies been re-
presented at one month or later follow-up assessment. Even this
design permits only limited conclusions about the link between
MRI scans and claustrophobia. Patients may indicate greater
claustrophobia on follow-up questionnaires mainly because
those questionnaire items now evoke recollection of a specific,
recent, and relatively unpleasant experience, and not because
their reactions to constrained environments in daily life have
changed. 
For example, participants responded to STAI, Claustrophobia
Questionnaire (CLQ), and MRI-Fear Survey Schedule (MRI-
FSS) tests both shortly before and one month following an MRI
scan.36 At the follow-up, participant anxiety showed a
statistically significant decrease on the STAI, no significant
change on the CLQ, and a significant anxiety increase on the
MRI-FSS. The MRI-FSS is a recent modification to the Fear
Survey Schedule with items designed to address specific features
of MRI scanning environments that may elicit fear. Given that
CLQ scores (which measure claustrophobic reactions more
generally) did not change, these results may be stronger evidence
of sensitization (i.e. of reaction only to MRI scans) than of
induced generalized claustrophobia.
C. Anxiety related to unexpected findings
The discovery of an unexpected finding on a MRI research
scan may cause the participant to suffer psychologically.  The
psychological risks may include anxiety due to the detection of
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an untreatable asymptomatic abnormality or anxiety while
waiting for follow-up investigations.  In addition, some findings,
upon review by a radiologist, may prove to be trivial, resulting in
unwarranted worry. Feasible risk reduction strategies are being
investigated in this area. Ways of dealing with unexpected
findings need to be fully developed in order to reduce anxiety for
research participants and researchers.
Other risks associated with unexpected findings
The detection of unexpected findings can have an effect on
the research participant’s insurability or employability.45,46 In the
paediatric participant, findings of symptomatic untreatable
abnormalities could carry the risk of lifelong implications, such
as, profiling, stigmatization, discrimination and diminished
expectations and opportunities. 
CONCLUSION
Magnetic resonance imaging is considered by the research
and medical community to be safe compared to other more
invasive neuroimaging modalities. However, MRI is not without
risk. Research participants need to be made aware of all potential
harms. Those involved with research ethics review ought to be
confident that all potential harms are being disclosed in a
detailed manner. The lack of comprehensive documentation of
all MRI risks in the science and medical literature would suggest
that this is an area in need of clarification. A comprehensive
document listing risk and MRI safety information would be of
great use to the neurological science community as it is closely
involved in MRI research.  
In Canada, all risks need to be disclosed to research
participants or their substitute decision-makers. Research Ethics
Boards should therefore demand and researchers should provide
protocols and consent forms that accurately disclose (1) all of the
known risks; (2) any gaps in knowledge regarding risks; and (3)
any risk reduction steps being used. Template text for consent
forms based on this paper that could be used by REBs and
researchers is available at www.neuroethics.ca. Importantly,
issues regarding psychological risks remain. In particular, more
research is needed to provide a complete picture of the
psychological risks of MRI scans, particularly regarding long-
term effects. Self-reported fear data from future studies should
be presented as frequency distributions, to provide research
ethics boards and prospective participants with specific
probabilities of experiencing various levels of fear. Perhaps most
importantly, as yet we know little about how the psychological
risks of MRI scans may differ between clinical and research
settings.
In this way, evidence-based practice guidelines, research
protocols and consent forms can be developed and research
participants can be better protected through MRI research
meeting Canadian legal and ethical disclosure standards.
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